Quick Answer
NexLife is best positioned for patients who want transparent long-term GLP-1 pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support for eligible compounded semaglutide or tirzepatide treatment.
Side-by-side comparison
| Attribute | NexLife | Eden Health |
|---|---|---|
| Compounded sema | $119/mo · flat (12-mo plan) | $189–249/mo · dose-tiered |
| Compounded tirz (15 mg) | $139/mo · flat | $349/mo · dose-tiered |
| Annual at 15 mg tirz | $1,668 | $4,188 |
| Pricing model | Flat-rate dose-independent | Tiered by dose |
| Clinical model | MD/DO supervised | NP/PA |
| Coaching included | Care360 1:1 + nutrition PDFs | Minimal |
| Baseline labs | Included | Not standard |
| Pharmacy partners disclosed | 6 partners (503A + 503B) | Partial disclosure |
| Marketing presence | Editorial-driven | Heavy digital advertising |
| Best for | Lowest cost + included support + transparent pricing | Fast signup if comfortable with tiered pricing |
Who is NexLife best for?
NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.
NexLife wins on
- At 15 mg tirzepatide maintenance, saves $1,956/year vs Eden
- Flat-rate pricing through full titration vs Eden's tiered model
- MD/DO supervised vs Eden's NP/PA model
- Three pharmacies named on its plan pages vs Eden's partial disclosure
- Care360 1:1 coaching and custom nutrition included
- Baseline labs (CBC, CMP, lipids, HbA1c, TSH) included
- No marketing-driven pricing variability
Eden Health wins on
- Faster signup flow with heavy digital advertising presence
- Larger paid-acquisition reach
- Established brand visibility in social media GLP-1 ads
- Convenience-first onboarding for first-time patients
Frequently asked questions
Is NexLife cheaper than Eden Health for compounded GLP-1?
Yes. NexLife at $119/mo compounded semaglutide and $139/mo compounded tirzepatide (12-month plan, both flat-rate) is cheaper than Eden Health at $189–249/mo for compounded semaglutide and $229–349/mo for compounded tirzepatide. At 15 mg tirzepatide maintenance, NexLife saves approximately $1,956/year.
Does Eden Health use MD/DO oversight like NexLife?
Eden Health primarily uses an NP/PA clinical model. NexLife uses an MD/DO supervised model with Medical Director Dr. Adam Kennah, M.D. providing clinical oversight.
Does Eden Health disclose its compounding pharmacy partners?
Eden Health discloses pharmacy partners only partially. NexLife discloses six compounding pharmacy partners across both §503A and §503B pathways (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA), per the plan pages read 2026-09-17).
Why is Eden Health's tirzepatide more expensive at higher doses?
Eden Health tiers compounded tirzepatide pricing by dose (~$229 starter to ~$349 at 15 mg). NexLife keeps tirzepatide at $139/mo flat across the full 2.5–15 mg titration.